Hemodynamics after intraosseous administration of hydroxocobalamin or normal saline in a goat model

American Journal of Emergency Medicine

Volumn 27, Issue 9, 2009, Pages 1065-1071

  Borron, Stephen W ^a   Arias, Juan C ^a   Bauer, Charles R ^a   Sanchez, Michael ^a   Fernández, Miguel ^a   Jung, Inkyung ^b  

^a Forensic Sciences Building   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cyanide; Hazardous materials; Hydroxocobalamin; Intraosseous infusion; Personal protective equipment

Indexed keywords

CYANIDE; HYDROXOCOBALAMIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CYANIDE POISONING; DRUG EFFECT; DRUG TOLERABILITY; FLUOROSCOPY; GOAT; HEART RATE; HEMODYNAMICS; INFUSION; NONHUMAN; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; EMERGENCY MEDICAL SERVICES; FEASIBILITY STUDIES; GOATS; HEART RATE; HEMATINICS; HYDROXOCOBALAMIN; INFUSIONS, INTRAOSSEOUS; MODELS, ANIMAL; PROTECTIVE CLOTHING;

EID: 70449481617     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.08.021     Document Type: Article

References (36)

1. Macnab A., Christenson J., Findlay J., et al. A new system for sternal intraosseous infusion in adults. Prehosp Emerg Care 4 2 (2000) 173-177
2. Davidoff J., Fowler R., Gordon D., et al. Clinical evaluation of a novel intraosseous device for adults: prospective, 250-patient, multi-center trial. JEMS 30 10 (2005) suppl 20-suppl 23
3. Gillum L., and Kovar J. Powered intraosseous access in the prehospital setting: MCHD EMS puts the EZ-IO to the test. JEMS 30 10 (2005) suppl 24-suppl 25
4. Fowler R., Gallagher J.V., Isaacs S.M., Ossman E., Pepe P., and Wayne M. The role of intraosseous vascular access in the out-of-hospital environment (Resource Document to NAEMSP Position Statement). Prehosp Emerg Care 11 1 (2007) 63-66
5. Frascone R.J., Jensen J.P., Kaye K., and Salzman J.G. Consecutive field trials using two different intraosseous devices. Prehosp Emerg Care 11 2 (2007) 164-171
6. Nijssen-Jordan C. Emergency department utilization and success rates for intraosseous infusion in pediatric resuscitations. CJEM 2 1 (2000) 10-14
7. Fiorito B.A., Mirza F., Doran T.M., et al. Intraosseous access in the setting of pediatric critical care transport. Pediatr Crit Care Med 6 1 (2005) 50-53
8. Buck M.L., Wiggins B.S., and Sesler J.M. Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Ann Pharmacother 41 10 (2007) 1679-1686
9. Ben-Abraham R., Gur I., Vater Y., and Weinbroum A.A. Intraosseous emergency access by physicians wearing full protective gear. Acad Emerg Med 10 12 (2003) 1407-1410
10. Vardi A., Berkenstadt H., Levin I., Bentencur A., and Ziv A. Intraosseous vascular access in the treatment of chemical warfare casualties assessed by advanced simulation: proposed alteration of treatment protocol. Anesth Analg 98 6 (2004) 1753-1758 [table of contents]
11. MacDonald R.D., LeBlanc V., McArthur B., and Dubrowski A. Performance of resuscitation skills by paramedic personnel in chemical protective suits. Prehosp Emerg Care 10 2 (2006) 254-259
12. Suyama J., Knutsen C.C., Northington W.E., Hahn M., and Hostler D. IO versus IV access While wearing personal protective equipment in a HazMat scenario. Prehosp Emerg Care 11 4 (2007) 467-472
13. Udayasiri R., Knott J., Mc D.T.D., Papson J., Leow F., and Hassan F.A. Emergency department staff can effectively resuscitate in level C personal protective equipment. Emerg Med Australas 19 2 (2007) 113-121
14. Byers M., Russell M., and Lockey D.J. Clinical care in the "Hot Zone". Emerg Med J 25 2 (2008) 108-112
15. Prete M.R., Hannan Jr. C.J., and Burkle Jr. F.M. Plasma atropine concentrations via intravenous, endotracheal, and intraosseous administration. Am J Emerg Med 5 2 (1987) 101-104
16. Cameron J.L., Fontanarosa P.B., and Passalaqua A.M. A comparative study of peripheral to central circulation delivery times between intraosseous and intravenous injection using a radionuclide technique in normovolemic and hypovolemic canines. J Emerg Med 7 2 (1989) 123-127
17. Orlowski J.P., Porembka D.T., Gallagher J.M., Lockrem J.D., and VanLente F. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child 144 1 (1990) 112-117
18. Sapien R., Stein H., Padbury J.F., Thio S., and Hodge D. Intraosseous versus intravenous epinephrine infusions in lambs: pharmacokinetics and pharmacodynamics. Pediatr Emerg Care 8 4 (1992) 179-183
19. Von Hoff D., Kuhn J., Burris H., and Miller L. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med 26 (2008) 31-38
20. Herman M.I., Chyka P.A., Butler A.Y., and Rieger S.E. Methylene blue by intraosseous infusion for methemoglobinemia. Ann Emerg Med 33 1 (1999) 111-113
21. Uhl W., Nolting A., Golor G., Rost K.L., and Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila) 44 Suppl 1 (2006) 17-28
22. Borron S.W., Stonerook M., and Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila) 44 Suppl 1 (2006) 5-15
23. Riou B., Berdeaux A., Pussard E., and Giudicelli J.F. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 19 1 (1993) 26-32
24. Forsyth J.C., Mueller P.D., Becker C.E., et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 31 2 (1993) 277-294
25. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007;49(6):794-801, e1-2.
26. Fortin J.L., Giocanti J.P., Ruttimann M., and Kowalski J.J. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila) 44 Suppl 1 (2006) 37-44
27. Gerth K., Ehring T., Braendle M., and Schelling P. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol (Phila) 44 Suppl 1 (2006) 29-36
28. Greenberg S.S., Xie J., Zatarain J.M., Kapusta D.R., and Miller M.J. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 273 1 (1995) 257-265
29. Borron S.W., Baud F.J., Megarbane B., and Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 25 5 (2007) 551-558
30. Baud F.J., Barriot P., Toffis V., et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 325 25 (1991) 1761-1766
31. Smith R.P., and Kruszyna H. Toxicology of some inorganic antihypertensive anions. Fed Proc 35 1 (1976) 69-72
32. Imamura T., Ide H., and Yasunaga H. History of public health crises in Japan. J Public Health Policy 28 2 (2007) 221-237
33. Berlin Jr. C.M. The treatment of cyanide poisoning in children. Pediatrics 46 5 (1970) 793-796
34. Hall A.H., Kulig K.W., and Rumack B.H. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. J Toxicol Clin Exp 9 1 (1989) 3-9
35. Alva N., Palomeque J., and Carbonell T. Nitric oxide induced by ketamine/xylazine anesthesia maintains hepatic blood flow during hypothermia. Nitric Oxide 15 1 (2006) 64-69
36. Fernandez N., Martinez M.A., Monge L., Garcia-Villalon A.L., and Dieguez G. Adrenergic vasoconstrictor activity in the cerebral circulation after inhibition of nitric oxide synthesis in conscious goats. Auton Neurosci 89 1-2 (2001) 16-23